Jean Nichols

Health Technology

Consumer Services

Finance

Profile

Jean Nichols was the President of Seragen, Inc. and Gloucester Pharmaceuticals, Inc. before becoming the Chief Operating Officer of Stonegate Partners LLC.
Prior to her business career, she was a Faculty Member at Harvard University.
Nichols holds an undergraduate and doctorate degree from The University of North Carolina at Charlotte.

Former positions of Jean Nichols

Companies	Position	End
Gloucester Pharmaceuticals, Inc. Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA	President	26/04/2011
Harvard University Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-
Stonegate Partners LLC Stonegate Partners LLC Financial ConglomeratesFinance Stonegate Partners LLC is a private equity firm.	Chief Operating Officer	-
Seragen, Inc. Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million.	President	-

See the detail of Jean Nichols's experience

Training of Jean Nichols

The University of North Carolina at Charlotte

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies